Literature DB >> 7509653

Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34.

O Majdic1, J Stöckl, W F Pickl, J Bohuslav, H Strobl, C Scheinecker, H Stockinger, W Knapp.   

Abstract

The transmembrane glycoprotein CD34 shows a highly restricted expression on a crucial subset of hematopoietic cells. We show here that engagement of particular determinants of CD34 can lead to signal transduction and to enhanced adhesiveness of CD34+ hematopoietic cells. Monoclonal antibodies (MoAbs) directed against O-sialoglycoprotease-sensitive epitopes of CD34 (QBEND10, ICH3, BI.3C5, MY10) but not MoAbs against O-sialoglycoprotease-resistant epitopes (9F2, 8G12) induce actin polymerization in KG-1a and KG-1 cells and strongly enhanced cytoadhesiveness. The capacity to induce adhesion requires cellular energy, divalent cations, and intact cytoskeleton but not de novo protein synthesis. The observed cytoadhesion seems at least in part to be caused by a concomitant activation of the beta 2 integrin cytoadhesion pathway. It can be significantly inhibited with lymphocyte function-associated antigen-1 and intercelluar adhesion molecule-1 antibodies. Protein kinase inhibition analyses suggest that the pathways initiated by engagement of the CD34 molecule with certain CD34 MoAbs involves protein tyrosine kinases but that protein kinase C is not critically involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509653

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings.

Authors:  Alexander R Mackie; Douglas W Losordo
Journal:  Tex Heart Inst J       Date:  2011

2.  Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.

Authors:  B Toth; M Wehrmann; E Kaiserling; H P Horny
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes.

Authors:  Franck Festy; Laurence Hoareau; Sandrine Bes-Houtmann; Anne-Marie Péquin; Marie-Paule Gonthier; Ashik Munstun; Jean Jacques Hoarau; Maya Césari; Régis Roche
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

Review 4.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

Review 6.  Crosstalk between Stem and Progenitor Cellular Mediators with Special Emphasis on Vasculogenesis.

Authors:  Rokhsareh Rohban; Barbara Prietl; Thomas R Pieber
Journal:  Transfus Med Hemother       Date:  2017-06-06       Impact factor: 3.747

7.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms.

Authors:  Y Natkunam; R V Rouse; S Zhu; C Fisher; M van De Rijn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

8.  Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells.

Authors:  Kian-Ngiap Chua; Chou Chai; Peng-Chou Lee; Seeram Ramakrishna; Kam W Leong; Hai-Quan Mao
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

9.  QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.

Authors:  H P Horny; M Wehrmann; H U Schlicker; A Eichstaedt; M R Clemens; E Kaiserling
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 10.  The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.

Authors:  Im-Soon Lee; Seok Hyung Kim; Hyung Geun Song; Seong Hoe Park
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.